Revcovi
Southern Health and Social Care TrustcontractFind a Tender ↗Ref ocds-h6vhtk-0592c8Procurement Act 2023pending
Estimated value
—
Awarded value
£4.0m
Awarded 02 Sept 2025
Suppliers
1
Lots
1
1 awarded
Published
03 Sept 2025
Description
Procurement of Revcovi, an approved enzyme replacement therapy (ERT) indicated for the treatment of adenosine deaminase severe combined immune deficiency.
Scope
- Reference
- ocds-h6vhtk-0592c8
- Commercial tool
- Standalone contract
Submission & procedure
- Procedure
- Direct award
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£4.0m
Award date
02 Sept 2025
Contract start
14 Sept 2025
Contract end
14 Sept 2028
Awarded to
CL
CH 02140985